New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2014
08:50 EDTDXCMDexCom upgraded at Sterne Agee
As noted earlier, Sterne Agee upgraded DexCom to Buy from Neutral. The firm expects the company to generate strong annual revenue growth, and believes that use of its G4 Platinum product will become more widespread after the FDA approved it for people ages 2-17. Target $50.
News For DXCM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
16:16 EDTDXCMDexCom files to sell 404,591 shares of common stock
Subscribe for More Information
August 25, 2015
16:43 EDTDXCMOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
08:32 EDTDXCMDexCom wins FDA approval for G5 mobile continuous glucose monitoring system
DexCom announced that the U.S. Food and Drug Administration has approved the Dexcom G5 Mobile Continuous Glucose Monitoring System. With wireless Bluetooth technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver. The new transmitter securely sends vital glucose information directly to an app on iOS-enabled devices for real-time diabetes management. Android applications will follow early next year. Like its predecessor, the G4 PLATINUM CGM with Share, users can also select up to five designated recipients, or "followers". These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere.
08:32 EDTDXCMDexCom says FDA approves G5 Mobile Continuous Glucose Monitoring System
Subscribe for More Information
August 24, 2015
08:29 EDTDXCMWilliam Blair to hold a field trip
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use